Dr. Jun Zhou joined Crown Bioscience in 2019 with her Ph.D. degree in Cellular and Molecular Biology from University of Toledo in Ohio. During the time at Crown Bioscience, she played a leading role in the model engineering platform to develop immuno-oncology relevant in vivo, in vitro and organoids models using cutting-age technologies, such as CRISPR/Cas9, Tet-On/Off Technology etc. In addition to her primary focus, she's also leading multiple internal research projects, including the generation of cancer organoid biobank, in vitro compound screening using a broad selection of cancer cell lines and organoids, identification of new drug targets using CRISPR screening and bioinformatics. On top of these, she has also been actively leading preclinical R&D projects for external biopharma and biotech companies and assisted many pharmaceutical companies and institutions to move their pipeline into IND and clinical trials.